Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 36.

Hoffman, Lindsey M; Veldhuijzen van Zanten, Sophie E M; Colditz, Niclas; Baugh, Joshua; Chaney, Brooklyn; Hoffmann, Marion; Lane, Adam; Fuller, Christine; Miles, Lili; Hawkins, Cynthia; Bartels, Ute; Bouffet, Eric; Goldman, Stewart; Leary, Sarah; Foreman, Nicholas K; Packer, Roger; Warren, Katherine E; Broniscer, Alberto; Kieran, Mark W; Minturn, Jane; Comito, Melanie; Broxson, Emmett; Shih, Chie-Schin; Khatua, Soumen; Chintagumpala, Murali; Carret, Anne Sophie; Escorza, Nancy Yanez; Hassall, Timothy; Ziegler, David S; Gottardo, Nicholas; et al; Grotzer, M A; Gerber, N U (2018). Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. Journal of Clinical Oncology, 36(19):1963-1972.

Boesten, T; Gerber, N U; Kandels, D; Azizi, A; Schmidt, R; Warmuth-Metz, M; Pietsch, Torsten; Kortmann, R D; Gnekow, A; Grotzer, M A (2016). Management of primary thalamic low-grade glioma in pediatric patients: results of the multicenter treatment studies HIT-LGG 1996 and SIOP-LGG 2004. Neuro-Oncology Practice:Epub ahead of print.

Thompson, E M; Hielscher, T; Bouffet, E; Remke, M; Luu, B; Gururangan, S; Grotzer, M A; Shalaby, T; et al (2016). Prognostic value of medulloblastoma surgical cytoreduction after accounting for molecular subgroup. Lancet Oncology, 17(4):484-495.

Shalaby, T; Achini, F; Grotzer, M A (2016). Targeting cerebrospinal fluid for discovery of brain cancer biomarkers. Journal of cancer metastasis and treatment, 2016(2):176-187.

Grotzer, M A; Schültke, E; Bräuer-Krisch, E; Laissue, J A (2015). Microbeam radiation therapy: clinical perspectives. Physica Medica, 31(6):564-567.

Fiaschetti, G; Abela, L; Nonoguchi, N; Dubuc, A M; Remke, M; Boro, A; Grunder, E; Siler, U; Ohgaki, H; Taylor, M D; Baumgartner, M; Shalaby, T; Grotzer, M A (2014). Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. British Journal of Cancer, 110(3):636-647.

Burkhardt, J K; Neidert, Marian C; Grotzer, M A; Krayenbühl, N; Bozinov, O (2013). Surgical resection of pediatric skull base meningiomas. Child's Nervous System, 29(1):83-87.

von Bueren, A O; Bacolod, M D; Hagel, C; Heinimann, K; Fedier, A; Kordes, U; Pietsch, T; Koster, J; Grotzer, M A; Friedman, H S; Marra, G; Kool, M; Rutkowski, S (2012). Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. British Journal of Cancer, 107(8):1399-1408.

Guerreiro, A S; Fattet, S; Kulesza, D W; Atamer, A; Elsing, A N; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2011). A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Molecular Cancer Research, 9(7):925-935.

Fiaschetti, G; Castelletti, D; Zoller, S; Schramm, A; Schroeder, C; Nagaishi, M; Stearns, D; Mittelbronn, M; Eggert, A; Westermann, F; Ohgaki, H; Shalaby, T; Pruschy, M; Arcaro, A; Grotzer, M A (2011). Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene, 30(25):2823-2835.

Grotzer, M A; Shalaby, T; Arcaro, A (2011). Central nervous system atyypical teratoid/rhabdoid tumors: role of insulin-like factor I receptor. In: Hayat, M A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Brain Cancer. Heidelberg: Springer, 353-364.

Faoro, D; von Bueren, A O; Shalaby, T; Sciuscio, D; Hürlimann, M L; Arnold, L; Gerber, N U; Haybaeck, J; Mittelbronn, M; Rutkowski, S; Hegi, M; Grotzer, M A (2011). Expression of O(6)-methylguanine-DNA methyltransferase in childhood medulloblastoma. Journal of Neuro-Oncology, 103(1):59-69.

Perret, C; Boltshauser, E; Scheer, I; Kellenberger, C J; Grotzer, M A (2011). Incidental findings of mass lesions on neuroimages in children. Neurosurgical Focus, 31(6):E20.

Fiaschetti, G; Grotzer, M A; Shalaby, T; Castelletti, D; Arcaro, A (2011). Quassinoids: From traditional drugs to new cancer therapeutics. Current Medicinal Chemistry, 18(3):316-328.

Oehler, C; von Bueren, A O; Furmanova, P; Broggini-Tenzer, A; Orlowski, K; Rutkowski, S; Frei, K; Grotzer, M A; Pruschy, M (2011). The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells. Neuro-Oncology, 13(9):1000-1010.

Grotzer, M A; Shalaby, T (2011). Translational Investigations of Liver Tumors: Sampling Strategies and Banking. In: Zimmermann, A. Pediatric liver tumors. Berlin Heidelberg: Springer, 53-58.

von Bueren, A O; Oehler, C; Shalaby, T; von Hoff, K; Pruschy, M; Seifert, Burkhardt; Gerber, N U; Warmuth-Metz, M; Stearns, D; Eberhart, C G; Kortmann, R D; Rutkowski, S; Grotzer, M A (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer, 11:74.

Castelletti, D; Fiaschetti, G; Di Dato, V; Ziegler, U; Kumps, C; De Preter, K; Zollo, M; Speleman, F; Shalaby, T; De Martino, D; Berg, T; Eggert, A; Arcaro, A; Grotzer, M A (2010). The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors. Molecular Cancer Therapeutics, 9(12):3145-3157.

Shalaby, T; Hiyama, E; Grotzer, M A (2010). Telomere maintenance as therapeutic target in embryonal tumours. Anti-Cancer Agents in Medicinal Chemistry, 10(3):196-212.

von Hoff, K; Hartmann, W; von Bueren, A O; Gerber, N U; Grotzer, M A; Pietsch, T; Rutkowski, S (2010). Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatric Blood & Cancer, 54(3):369-376.

Kukal, K; Dobrovoljac, M; Boltshauser, E; Ammann, R A; Grotzer, M A (2009). Does diagnostic delay result in decreased survival in paediatric brain tumours? European Journal of Pediatrics, 168(3):303-310.

Zuzak, T J; Balmer, B; Schmidig, D; Boltshauser, E; Grotzer, M A (2009). Magnetic toys: forbidden for pediatric patients with certain programmable shunt valves? Child's Nervous System, 25(2):161-164.

Gruber-Olipitz, M; Ströbel, T; Kang, S U; John, J P P; Grotzer, M A; Slavc, I; Lubec, G (2009). Neurotrophin 3/TrkC-regulated proteins in the human medulloblastoma cell line DAOY. Electrophoresis, 30(3):540-549.

von Bueren, A O; Shalaby, T; Oehler-Jänne, C; Arnold, L; Stearns, D; Eberhart, C G; Arcaro, A; Pruschy, M; Grotzer, M A (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer, 9:10.

Grotzer, M A; Castelletti, D; Fiaschetti, G; Shalaby, T; Arcaro, A (2009). Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Current Cancer Drug Targets, 9(2):176-188.

Gruber-Olipitz, M; Ströbel, T; Chen, W; Grotzer, M A; Quehenberger, F; Slavc, I; Lubec, G (2008). Synthesis, chaperoning, and metabolism of proteins are regulated by NT-3/TrkC signaling in the medulloblastoma cell line DAOY. Journal of Proteome Research, 7(5):1932-1944.

Haeberli, S; Grotzer, M A; Niggli, F K; Landolt, M A; Linsenmeier, C; Ammann, R A; Bodmer, N (2008). A psychoeducational intervention reduces the need for anesthesia during radiotherapy for young childhood cancer patients. Radiation Oncology, 3:17.

Wiegering, V A; Kellenberger, C J; Bodmer, N; Bergstraesser, E; Niggli, F K; Grotzer, M A; Nadal, D; Bourquin, J P (2008). Conservative management of acute appendicitis in children with hematologic malignancies during chemotherapy-induced neutropenia. Journal of Pediatric Hematology/Oncology, 30(6):464-467.

Poretti, A; Zehnder, D; Boltshauser, E; Grotzer, M A (2008). Long-term complications and quality of life in children with intraspinal tumors. Pediatric Blood & Cancer, 50(4):844-848.

Huang, J; Grotzer, M A; Watanabe, T; Hewer, E; Pietsch, T; Rutkowski, S; Ohgaki, H (2008). Mutations in the Nijmegen breakage syndrome gene in medulloblastomas. Clinical Cancer Research, 14(13):4053-4058.

Gerber, N U; Zehnder, D; Zuzak, T J; Poretti, A; Boltshauser, E; Grotzer, M A (2008). Outcome in children with brain tumours diagnosed in the first year of life: long-term complications and quality of life. Archives of Disease in Childhood, 93(7):582-589.

Zuzak, T J; Poretti, A; Drexel, B; Zehnder, D; Boltshauser, E; Grotzer, M A (2008). Outcome of children with low-grade cerebellar astrocytoma: long-term complications and quality of life. Child's Nervous System, 24(12):1447-1455.

Guerreiro, A S; Fattet, S; Fischer, B; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2008). Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration. Clinical Cancer Research, 14(21):6761-6769.

Boller, D; Schramme, A; Doepfner, K T; Shalaby, T; von Bueren, A O; Eggert, A; Grotzer, M A; Arcaro, A (2008). Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. Clinical Cancer Research, 14(4):1172-1181.

Oehler-Jänne, C; von Bueren, A O; Vuong, V; Hollenstein, A; Grotzer, M A; Pruschy, M (2008). Temperature sensitivity of phospho-Ser(473)-PKB/AKT. Biochemical and Biophysical Research Communications (BBRC), 375(3):399-404.

Ribi, K; Relly, C; Landolt, M A; Alber, F D; Boltshauser, E; Grotzer, M A (2005). Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics, 36(6):357-365.

This list was generated on Wed Jun 26 15:19:26 2019 CEST.